| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q5QQ08 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| Q8N798 | cDNA FLJ25878 fis, clone CBR02538; Fragment; | NULL | NULL | 338 | human |
| Q7Z5L6 | E2A/PBX1 fusion protein; Fragment; | E2A/PBX1; fusion; | NULL | 72 | human |
| Q6ZS45 | cDNA FLJ45844 fis, clone OCBBF2003518; | NULL | NULL | 600 | human |
| Q7Z4U9 | Putative uncharacterized protein; | NULL | NULL | 303 | human |
| Q16340 | Phosphodiesterase beta-subunit protein; Fragment; | phosphodiesterase; beta-subunit; | NULL | 52 | human |
| Q6ZRT9 | cDNA FLJ46112 fis, clone TESTI2035962; | NULL | NP_001139782.1; | 230 | human |
| Q6ZNT3 | CDNA FLJ27206 fis, clone SYN03441; | NULL | NULL | 138 | human |
| Q9H282 | Serologically defined breast cancer antigen NY-BR-46; Fragment; | NULL | NULL | 40 | human |
| Q8NEU3 | TTL/TEL fusion protein TTL-T; | TTL/TEL; fusion; | NULL | 133 | human |
| Q8WY27 | Candidate tumor suppressor protein; Fragment; | LRP1B; | NULL | 79 | human |
| Q7Z580 | 5-hydroxytryptamine receptor 2B variant b; Fragment; | HTR2B; | NULL | 53 | human |
| Q6ZV51 | cDNA FLJ42984 fis, clone BRTHA2008335; | NULL | NULL | 180 | human |
| Q96L49 | Truncated NK cell receptor; Fragment; | KIR2DL4; | NULL | 130 | human |
| Q7YQ49 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| Q6MZX6 | Putative uncharacterized protein DKFZp686J06205; | DKFZp686J06205; | NULL | 106 | human |
| Q8WWJ4 | T cell surface glycoprotein CD6 isoform d; | CD6; | NULL | 601 | human |
| Q6RKX7 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| Q96JR4 | PRO0777; | NULL | NULL | 114 | human |
| Q6ZR98 | cDNA FLJ46533 fis, clone THYMU3036953, weakly similar to Homo sapiens mosaic serine protease; MSP; | NULL | XP_003403815.4;XP_003960020.2;XP_003960378.2; | 141 | human |
